Document 0588 DOCN M9550588 TI Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. DT 9505 AU Michael NL; Mo T; Merzouki A; O'Shaughnessy M; Oster C; Burke DS; Redfield RR; Birx DL; Cassol SA; Division of Retrovirology, Walter Reed Army Institute of; Research, Rockville, Maryland. SO J Virol. 1995 Mar;69(3):1868-77. Unique Identifier : AIDSLINE MED/95156620 AB We report the results of a longitudinal study of RNA splicing patterns in 31 early-stage human immunodeficiency virus disease patients with an average follow-up time of 3 years. Eighteen patients showed no evidence for disease progression, whereas 13 patients either showed a > or = 50% reduction in baseline CD4 count or developed opportunistic infections. Levels of unspliced, tat, rev, and nef mRNAs in peripheral blood mononuclear cells were measured by a reverse transcriptase-quantitative, competitive PCR assay. Viral RNA was detected in all patients at all time points. All 13 rapid progressors had viral RNA loads that were > or = 1 log unit greater than those of the slow progressors. In addition, seven of the rapid progressors showed a reduction of more than threefold in the ratio of spliced to unspliced RNA over the 3 years of follow-up. Conversely, two slow progressors with intermediate levels of viral RNA showed no splicing shift. These results confirm earlier observations that viral RNA is uniformly expressed in early-stage patients. We further show that cellular RNA viral load is predictive of disease progression. Importantly, the shift from a predominately spliced or regulatory viral mRNA pattern to a predominately unspliced pattern both is associated with disease progression and adds predictive utility to measurement of either RNA class alone. DE AIDS Vaccines/IMMUNOLOGY Base Sequence CD4 Lymphocyte Count DNA Primers/CHEMISTRY *Gene Expression Regulation, Viral Human HIV Infections/*MICROBIOLOGY/PATHOLOGY HIV-1/*GENETICS Longitudinal Studies Molecular Sequence Data Prognosis RNA Splicing RNA, Messenger/GENETICS RNA, Viral/*GENETICS Time Factors JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).